01 1Cambrex Corporation
01 1BUPIVACAINE HYDROCHLORIDE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-10-18
Pay. Date : 2019-10-15
DMF Number : 5984
Submission : 1985-08-27
Status : Active
Type : II
20
Cambrex Karlskoga Ab, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is BUPIVACAINE HYDROCHLORIDE, with a corresponding US DMF Number 5984.
Remarkably, this DMF maintains an Active status since its submission on August 27, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 18, 2019, and payment made on October 15, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
